Prospective Randomized Trial of Hepatic Artery Chemotherapy With Cisplatin and Doxorubicin, With or Without Lipiodol in the Treatment of Advanced Stage Hepatocellular Carcinoma

PURPOSEThis randomized study assessed the responses in hepatocellular carcinoma (HCC) to hepatic arterial doxorubicin plus cisplatin, with or without lipiodol. PATIENTS AND METHODSPatients with unresectable and biopsy-proven HCC were treated with doxorubicin (30 mg/m) plus cisplatin (100 mg/m) witho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical gastroenterology 2011-10, Vol.45 (9), p.e87-e91
Hauptverfasser:	Carr, Brian Irving, Bron, Klaus, Swanson, Dennis P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic - methods Cisplatin - administration & dosage Disease Progression Doxorubicin - administration & dosage Ethiodized Oil - administration & dosage Female Hepatic Artery Humans Infusions, Intra-Arterial Liver Neoplasms - pathology Liver Neoplasms - therapy Male Middle Aged Neoplasm Staging Prospective Studies Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!